MedTrace Logo

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer

NCT03633006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3298

Last updated 2021-02-15

No results posted yet for this study

Summary

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.

Conditions

  • Lung Cancer (Diagnosis)

Interventions

OTHER

Blood Sample Collection

Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment.

OTHER

Blood Sample Collection

Subjects participating in the study will have blood drawn at enrollment. Additional blood samples may be collected at 12 months from enrollment if lung cancer has not been confirmed.

OTHER

Blood Sample Collection

Subjects participating in the study will have blood drawn at enrollment.

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Principal Investigators

  • Laura Strong · Exact Sciences

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-11
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03633006 on ClinicalTrials.gov